Authors:
Hansen, DL
Astrup, A
Toubro, S
Finer, N
Kopelman, P
Hilsted, J
Rossner, S
Saris, WHM
Van Gaal, LF
James, WPT
Goulder, M
Citation: Dl. Hansen et al., Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre STORM trial, INT J OBES, 25(4), 2001, pp. 496-501
Authors:
Finer, N
Bloom, SR
Frost, GS
Banks, LM
Griffiths, J
Citation: N. Finer et al., Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study, DIABET OB M, 2(2), 2000, pp. 105-112
Authors:
Finer, N
James, WPT
Kopelman, PG
Lean, MEJ
Williams, G
Citation: N. Finer et al., One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor, INT J OBES, 24(3), 2000, pp. 306-313
Citation: N. Finer, Round Table (videoconference) on 'Management of obesity' - Prevention and management of obesity: pharmacology, P NUTR SOC, 59(3), 2000, pp. 413-413
Citation: P. Barrett et al., Evaluation of a multimodality treatment programme for weight management atthe Luton and Dunstable Hospital NHS Trust, J HUM NU DI, 12, 1999, pp. 43-52